InsiderTrades.com logo
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

ZBIO Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $46,863,839.00
Insider Selling (Last 12 Months): $0.00

ProShares UltraPro Short Nasdaq Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at ProShares UltraPro Short Nasdaq Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ProShares UltraPro Short Nasdaq Biotechnology Share Price & Price History

Current Price: $12.00
Price Change: ▲ Price Increase of +1.56 (14.94%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for ZBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

ProShares UltraPro Short Nasdaq Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2024Leon O Moulder JrCEOBuy7,500$15.00$112,500.00168,655View SEC Filing Icon  
9/20/2024Leon O Moulder JrCEOBuy5,000$18.45$92,250.001,672,039View SEC Filing Icon  
9/18/2024Leon O Moulder JrCEOBuy10,000$17.91$179,100.001,662,039View SEC Filing Icon  
9/16/2024Patrick G EnrightDirectorBuy440,000$17.00$7,480,000.00774,530View SEC Filing Icon  
9/16/2024Sr One Capital Management, LlcMajor ShareholderBuy2,235,294$17.00$37,999,998.001,946,564View SEC Filing Icon  
9/13/2024Hongbo LuDirectorBuy58,823$17.00$999,991.0058,823View SEC Filing Icon  
See Full Table
Bill Gates’s Next Big AI Bet: Stargate
From Brownstone Research   |   Ad
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.
I believe we are about to do it again with this new AI project called Stargate

SEC Filings (Institutional Ownership Changes) for ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO)

Zenas BioPharma Inc. is a clinical-stage global biopharmaceutical company. It involved in the development and commercialization of transformative immunology-based therapies for patients in need. The company's lead product candidate includes obexelimab and Fc?RIIb. Zenas BioPharma Inc. is based in WALTHAM, Mass.
Read More on ProShares UltraPro Short Nasdaq Biotechnology

Today's Range

Now: $12.00
Low: $9.45
High: $12.37

50 Day Range

MA: $10.05
Low: $10.02
High: $10.09

52 Week Range

Now: $12.00
Low: $8.28
High: $18.64

Volume

785,065 shs

Average Volume

153,469 shs

Market Capitalization

$501.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ProShares UltraPro Short Nasdaq Biotechnology?

ProShares UltraPro Short Nasdaq Biotechnology's top insider investors include:
  1. Sr One Capital Management, Llc (Major Shareholder)
  2. Leon O Moulder Jr (CEO)
  3. Patrick G Enright (Director)
  4. Hongbo Lu (Director)
Learn More about top insider investors at ProShares UltraPro Short Nasdaq Biotechnology.
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.